Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS.
This study analyzes the use of sodium nitroprusside (SN) as an option to reduce blood pressure (BP) below 180/105 mmHg during the management of acute ischemic stroke (AIS) in patients submitted to intravenous thrombolysis.Method The sample was composed by 60 patients who had AIS and were submitted to intravenous rtPA, split in two groups: half in the control group (CG) with BP < 180/105 mmHg and half in SN group with BP > 180/105 mmHg. Outcome variables were any hemorrhagic transformation (HT); the presence of symptomatic HT, National Institute of Health Stroke Scale (NIHSS) after 24 hours of treatment; the independence on discharge and death until three months after stroke onset.Results There were no statistical differences between both groups to any of the outcome variables analyzed.Conclusion The SN might be safe for BP control during thrombolysis to AIS.
Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, BR.
Jessyca L
JL
Koslyk
Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, BR.
Renata D
RD
Ducci
Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, BR.
Edison M
EM
Nóvak
Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, BR.
Viviane F
VF
Zétola
Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, BR.
Marcos C
MC
Lange
D000208:Acute Disease; D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D009599:Nitroprusside / Q000191:economics / Q000627:therapeutic use*; D020521:Stroke / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects* / Q000191:economics / Q000379:methods; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D009599:Nitroprusside